U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07649369) titled 'A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion' on June 10.
Brief Summary: This study aims to evaluate the efficacy and safety of intrapleural JMKX000197 compared with intrapleural cisplatin in patients with malignant pleural effusion.
Study Start Date: Aug. 17
Study Type: INTERVENTIONAL
Condition:
Malignant Pleural Effusions (Mpe)
Intervention:
DRUG: JMKX000197
Intrapleural administration
DRUG: Cisplatin
Intrapleural administration
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shanghai Jeyou Pharmaceutical Co., Ltd.
Published by HT Digital Content Serv...